Company Profile · Healthcare

Straumann Holding AG

STMN · SW
Exchange
SW
Country
Switzerland
Employees
11,319
Current Price
106.8
Jun 27, 2026 close
Fair Buy
76
Margin-of-safety entry
Baillie Growth Score
53/100
Medium
Intrinsic Value · Three-Tier Range Current price 106.8 · Within the fair intrinsic-value range

Composite valuation range · conservative 70–76 / fair 85–129 / optimistic 134–145. At 106.8, Within the fair intrinsic-value range.

Jun 17, 2026 Earnings Needs review

Straumann raised 2026 profitability outlook

Straumann raised its 2026 core EBIT margin expansion outlook, citing lower-than-expected tariffs and faster efficiency gains.

Possible impact:May affect expectations for full-year profitability and earnings upgrades.

The Wall Street JournalView source

Automatically summarized from public sources; for context only, not investment advice.

Market capCHF 16.5B
Revenue (TTM)CHF 2.61B
EBITDACHF 750.57M
Profit margin13.66%
ROE17.01%
P/E (TTM)46.39
Forward P/E32.79
PEG1.58
EPSCHF 2.23
Dividend yield0.95%
52-week rangeCHF 72.22 – CHF 110.27

Data from EODHD, shown in the reporting currency; for reference only, not investment advice.

Straumann Holding AG provides tooth replacement and orthodontic solutions in Switzerland, the United States, China, Germany, Brazil, Japan, France, and internationally. It operates through Sales Europe, Middle East and Africa; Sales North America; Sales Asia Pacific; Sales Latin America; and Operations segments. The company offers dental implants, instruments, CADCAM prosthetics, orthodontic and clear aligners, biomaterials, and digital equipment and solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. It also provides implant systems, components, and related instruments, as well as healing components, materials and surfaces, surgical sets and instruments, and guided surgery and navigation products; prosthetics, including angled solutions, connections, components, and molar solutions; intra-oral and lab scanners, milling machines, dynamic navigation systems, and 3D printers; consumables, such as blocks, discs, resins, titanium bases, and abutment blanks, as well as scan bodies, analogs, and sleeves; online education; and dentists and dental labs solutions. In addition, the company offers regenerative solutions for tooth preservation, implant-site management, and implant preservation; scanner hardware, software licenses, sterile-packaged products, customer training, and other products; and logistics and supply chain services. Further, it provides thermoplastics; implant treatment referral; high-tech materials; artificial intelligence solutions for dental applications; and 3D orthodontic treatment animations. The company sells its products under the Straumann, Neodent, Medentika, Anthogyr, ClearCorrect, NUVO, and other brands through a network of distribution subsidiaries and partners, and third-party distributors, as well as through its e-shop. It serves clinicals needs, patient segments, and healthcare systems. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

History

Coming soonThis section is being filled in — check back soon.

Industry position

Coming soonThis section is being filled in — check back soon.